NCT00090142View on ClinicalTrials.gov

Montelukast in Exercise-Induced Bronchospasm - 2004 (0476-275)

PHASE3CompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

May 31, 2004

Primary Completion Date

October 31, 2004

Study Completion Date

October 31, 2004

Conditions
Asthma, Exercise-Induced
Interventions
DRUG

Comparator: Montelukast

Montelukast 10 mg tablet administered orally as a single witnessed dose before exercise challenge

DRUG

Comparator: Placebo

Placebo tablet administered orally as a single witnessed dose before exercise challenge

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00090142 - Montelukast in Exercise-Induced Bronchospasm - 2004 (0476-275) | Biotech Hunter | Biotech Hunter